Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Legrand

Showing results (381-390 of 400) with videos related to

Pageof 40
Sort By:
Annales De Dermatologie Et De Venereologie|January 18, 2023
Burden of visible [face and hands] skin diseases: Results from a large international surveyM-A Richard, M Saint Aroman, C Baissac, et al.
Journal of Medical Virology|October 1, 1992
New developments in the molecular epidemiology of adenovirus 8 keratoconjunctivitisJ C de Jong, M Démazure, M C Legrand-Quillien, et al.
Journal of the National Cancer Institute|July 25, 2000
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trialJ A van Dongen, A C Voogd, I S Fentiman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975F Efficace, A Bottomley, E F Smit, et al.
The British Journal of Dermatology|July 22, 2014
Health-related quality of life in patients with melanoma expressed as utilities and disability weightsI Tromme, B Devleesschauwer, P Beutels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III studyV C Tjan-Heijnen, P E Postmus, A Ardizzoni, et al.
Oncology|June 5, 2010
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancerV Surmont, J G J V Aerts, R J van Klaveren, et al.
International Journal of Oncology|September 15, 1998
Differential transferrin receptor density in human colorectal cancer: A potential probe for diagnosis and therapyA C Prost, F Ménégaux, P Langlois, et al.
Journal of Viral Hepatitis|January 25, 2007
Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?S Vallet, S Gouriou, G Nkontchou, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992)P Baas, A Ardizzoni, F Grossi, et al.
Pageof 40

Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
Annales De Dermatologie Et De Venereologie|January 18, 2023
Burden of visible [face and hands] skin diseases: Results from a large international surveyM-A Richard, M Saint Aroman, C Baissac, et al.
Journal of Medical Virology|October 1, 1992
New developments in the molecular epidemiology of adenovirus 8 keratoconjunctivitisJ C de Jong, M Démazure, M C Legrand-Quillien, et al.
Journal of the National Cancer Institute|July 25, 2000
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trialJ A van Dongen, A C Voogd, I S Fentiman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975F Efficace, A Bottomley, E F Smit, et al.
The British Journal of Dermatology|July 22, 2014
Health-related quality of life in patients with melanoma expressed as utilities and disability weightsI Tromme, B Devleesschauwer, P Beutels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III studyV C Tjan-Heijnen, P E Postmus, A Ardizzoni, et al.
Oncology|June 5, 2010
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancerV Surmont, J G J V Aerts, R J van Klaveren, et al.
International Journal of Oncology|September 15, 1998
Differential transferrin receptor density in human colorectal cancer: A potential probe for diagnosis and therapyA C Prost, F Ménégaux, P Langlois, et al.
Journal of Viral Hepatitis|January 25, 2007
Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?S Vallet, S Gouriou, G Nkontchou, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992)P Baas, A Ardizzoni, F Grossi, et al.
Pageof 40